Clarapath Inc., a White Plains-based robotics company, has acquired Crosscope, a digital pathology company based in Mountain View, California.
The Crosscope Dx software platform was designed by pathologists to streamline the pathology process by enabling interoperability, storage, image management, and collaboration. The software provides a portfolio of AI applications to deliver an end-to-end digital pathology, and advanced, integrated, and highly flexible workflow features with an open and scalable architecture.
According to Claraptah, the acquisition combines and streamlines the company”™s SectionStar, an automated all-in-one tissue sectioning and transfer system, with Crosscope”™s workflow and computational pathology tools, with the goal of enabling labs to cost effectively deliver care with greater speed and efficiency.
“We believe that the combination of SectionStar”™s exceptional automated robotics with Crosscope”™s advanced workflow and computational pathology tools provide an end-to-end platform for more patient-centric care in human and animal health,” said Eric Feinstein, CEO of Clarapath. “Our combined offering will solve some of the most pressing issues in the lab such as labor shortages, quality control challenges, and the rapidly increasing volume of samples needing review.”
The terms of the acquisitions were not disclosed.
